(Q43594287)

English

Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Stanley I. Rapoport

6

object named as

S I Rapoport

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

M C Chang

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M A Contreras

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

T A Rosenberger

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

J J Rintala

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

J M Bell

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

77

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

796-803

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sodium valproate induced alterations in monoamine levels in different regions of the rat brain

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Effect of valproate on lipogenesis in neonatal rat brain.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Inhibition of neonatal brain fuel utilization by valproate and E-delta 2-valproate is not a consequence of the stimulation of the gamma-aminobutyric acid shunt.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Effect of valproate on the metabolism of the central nervous system.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Chronic lithium treatment decreases brain phospholipase A2 activity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Lithium decreases turnover of arachidonate in several brain phospholipids

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Mechanism of anticonvulsant action of valproate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Nutritional deprivation of alpha-linolenic acid decreases but does not abolish turnover and availability of unacylated docosahexaenoic acid and docosahexaenoyl-CoA in rat brain.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

The emerging role of valproate in bipolar disorder and other psychiatric disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Valproate treatment and platelet function: the role of arachidonate metabolites.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Properties and regulation of cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Effects of haloperidol, lithium, and valproate on phosphoinositide turnover in rat brain.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Incorporation of [3H]valproic acid into lipids in GT1-7 neurons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Prenatal valproic acid exposure decreases neuronal membrane order in rat offspring hippocampus and cortex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Is there a common denominator for the antimanic effect of lithium and anticonvulsants?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Effect of pyridoxal 5'-phosphate and valproic acid on phospholipid synthesis in neuroblastoma na

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00311.X

21 January 2018

Identifiers

10.1046/J.1471-4159.2001.00311.X

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43594287&oldid=2101765274"